Journal
JOURNAL OF MOLECULAR NEUROSCIENCE
Volume 52, Issue 1, Pages 124-130Publisher
HUMANA PRESS INC
DOI: 10.1007/s12031-013-0216-0
Keywords
Alzheimer's disease; A beta(1-42); Insulin receptor; Insulin resistance
Categories
Funding
- Natural Science foundation of Heilongjiang Province, China [ZJY0706]
Ask authors/readers for more resources
Amyloid beta (A beta) is an important pathogenic factor in Alzheimer's disease (AD). In this study, we investigated the hypothesis that administration of amyloid-derived diffusible ligands (ADDLs) prepared from a synthetic A beta (1-42) amyloid peptide can cause defective expression of insulin receptors (IRs). To this end, primary rat hippocampal neurons were treated with various concentrations of ADDLs and expression levels of IRs were measured using real-time PCR and western blots. In these experiments, the expression of IRs significantly increased following treatment with low concentrations of A beta (1-42). In contrast, when higher concentrations of A beta (1-42) were applied, the number of apoptotic cells present increased, and expression of IRs significantly decreased. In combination, these results suggest that ADDLs is able to induce abnormal expression of IRs and interrupt normal insulin signaling, thereby potentially contributing to central insulin resistance that can occur during progression of AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available